The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough.

"Declarations Conflict of interestLPM has received grants and personal fees from Merck Sharp & Dohme; personal fees from Applied Clinical Intelligence; grants from Asthma UK, Northern Ireland Chest Heart and Stroke, NC3Rs, British Heart Foundation, and Chiesi; travel and subsistence for attendance at scientific meetings from Boehringer Ingelheim, GlaxoSmithKline, and Chiesi; and advisory board or consultancy fees from Almirall, NAPP, GlaxoSmithKline, and Boehringer Ingelheim. MRS has received grants and personal fees from Merck & Co., Inc; is a consultant to Bayer, Bellus, and NeRRe Therapeutics; and has done clinical research with Bellus. YGS reports no conflicts. SL, WCW, PX, JS, CL, AMN, PAR, and ASA are current or former employees of Merck & Co., Inc., Rahway, NJ, USA. Conflict of interest LPM has received grants and personal fees from Merck Sharp & Dohme; personal fees from Applied Clinical Intelligence; grants from Asthma UK, Northern Ireland Chest Heart and Stroke, NC3Rs, British Heart Foundation, and Chiesi; travel and subsistence for attendance at scientific meetings from Boehringer Ingelheim, GlaxoSmithKline, and Chiesi; and advisory board or consultancy fees from Almirall, NAPP, GlaxoSmithKline, and Boehringer Ingelheim. MRS has received grants and personal fees from Merck & Co., Inc; is a consultant to Bayer, Bellus, and NeRRe Therapeutics; and has done clinical research with Bellus. YGS reports no conflicts. SL, WCW, PX, JS, CL, AMN, PAR, and ASA are current or former employees of Merck & Co., Inc., Rahway, NJ, USA."

"Funding Funding for this research was provided by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA."